These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25367912)

  • 1. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
    Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V
    Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
    Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
    Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.
    Plucinski MM; Dimbu PR; Macaia AP; Ferreira CM; Samutondo C; Quivinja J; Afonso M; Kiniffo R; Mbounga E; Kelley JS; Patel DS; He Y; Talundzic E; Garrett DO; Halsey ES; Udhayakumar V; Ringwald P; Fortes F
    Malar J; 2017 Feb; 16(1):62. PubMed ID: 28153004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
    Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
    Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda.
    Ebong C; Sserwanga A; Namuganga JF; Kapisi J; Mpimbaza A; Gonahasa S; Asua V; Gudoi S; Kigozi R; Tibenderana J; Bwanika JB; Bosco A; Rubahika D; Kyabayinze D; Opigo J; Rutazana D; Sebikaari G; Belay K; Niang M; Halsey ES; Moriarty LF; Lucchi NW; Souza SSS; Nsobya SL; Kamya MR; Yeka A
    Malar J; 2021 Dec; 20(1):484. PubMed ID: 34952573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya.
    Agarwal A; McMorrow M; Onyango P; Otieno K; Odero C; Williamson J; Kariuki S; Kachur SP; Slutsker L; Desai M
    Malar J; 2013 Jul; 12():254. PubMed ID: 23870627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India.
    Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N
    Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013.
    Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P
    Malar J; 2016 Jun; 15():331. PubMed ID: 27334876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
    Dorkenoo AM; Warsame M; Ataba E; Hemou M; Yakpa K; Sossou E; Mitigmsagou M; Teou CD; Caspar E; Ma L; Djadou KE; Atcha-Oubou T; Rasmussen C; Menard D
    Malar J; 2024 Apr; 23(1):92. PubMed ID: 38570791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
    Kakolwa MA; Mahende MK; Ishengoma DS; Mandara CI; Ngasala B; Kamugisha E; Kataraihya JB; Mandike R; Mkude S; Chacky F; Njau R; Premji Z; Lemnge MM; Warsame M; Menard D; Kabanywanyi AM
    Malar J; 2018 Oct; 17(1):369. PubMed ID: 30333022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo.
    Onyamboko MA; Fanello CI; Wongsaen K; Tarning J; Cheah PY; Tshefu KA; Dondorp AM; Nosten F; White NJ; Day NP
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5528-36. PubMed ID: 25001306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study.
    Ogutu BR; Onyango KO; Koskei N; Omondi EK; Ongecha JM; Otieno GA; Obonyo C; Otieno L; Eyase F; Johnson JD; Omollo R; Perkins DJ; Akhwale W; Juma E
    Malar J; 2014 Jan; 13():33. PubMed ID: 24472156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia.
    Warsame M; Hassan AM; Hassan AH; Jibril AM; Khim N; Arale AM; Gomey AH; Nur ZS; Osman SM; Mohamed MS; Abdulrahman A; Yusuf FE; Amran JGH; Witkowski B; Ringwald P
    Malar J; 2019 Jul; 18(1):231. PubMed ID: 31296223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau - An Open-Label Non-Inferiority Randomised Clinical Trial.
    Ursing J; Rombo L; Rodrigues A; Kofoed PE
    PLoS One; 2016; 11(9):e0161495. PubMed ID: 27649561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.